26.01.2018 • News

Ex-Lilly Executive Confirmed as US Health Secretary

Former Eli Lilly executive Alex Azar was confirmed by the US Senate as new...
Former Eli Lilly executive Alex Azar was confirmed by the US Senate as new Secretary of the Department of Health and Human Services (HHS) (c) HHS.gov

By vote of 55 to 43, former Eli Lilly executive Alex Azar was confirmed by the US Senate as new Secretary of the Department of Health and Human Services (HHS) on Jan. 24.

Azar formerly headed pharmaceutical giant Lilly’s US operations, but also has experience at HHS, where he served as general counsel from 2001 to 2005 and later as deputy secretary.

As secretary, Azar replaces Tom Price, former US representative from Georgia’s sixth congressional district. Price was forced to step down last year after it emerged that he had spent government funds on personal travel.

In his new job, the former pharma manager will be responsible for overseeing $1.13 trillion in department spending and supervising research and administering health programs.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read